Pilot Study Evaluating the Safety and Performance of the GeNO NITROsyl Delivery System for Inhaled Nitric Oxide
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This is an open label phase 2 pilot study designed to evaluate the safety, tolerability and
device performance of the GeNO nitrosyl delivery system during right heart catheterization
(RHC) in participants with pulmonary arterial hypertension (PAH). All participants will
receive inhaled nitric oxide in oxygen or nitric oxide in air delivered by nasal cannula.
Hemodynamics, clinical laboratory and clinical assessment data will be collected on all
participants to evaluate safety.